# US 2025/0171768 A1 · Method and apparatus for processing tissue samples

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0171768 A1
- Document ID: US20250171768A1
- Status: Published application
- Kind: A1
- Application number: 18/843,294
- Filed: 2023-03-02
- Published: 2025-05-29
- Earliest claimed: 2022-03-02
- Assignees: S2 Genomics, Inc.
- Applicants: S2 Genomics, Inc.
- Inventors: John BASHKIN; Stevan Bogdan JOVANOVICH; Danielle MEYER; Nathan PEREIRA; Kaiwan CHEAR; David EBERHART
- Web page: https://patentgrep.com/patent/US20250171768A1

## CPC

- C12N 15/1065: {Preparation or screening of tagged libraries, e.g. tagged microorganisms by STM-mutagenesis, tagged polynucleotides, gene tags}
- G01N 1/286: {involving mechanical work, e.g. chopping, disintegrating, compacting, homogenising (microtomes G01N1/06; pulverising in general B02C; mixing in general B01F)}
- B01L 3/502761: {specially adapted for handling suspended solids or molecules independently from the bulk fluid flow, e.g. for trapping or sorting beads or physically stretching molecules}
- B02C 18/143: {with a disc rotor having generally radially extending slots or openings bordered with cutting knives}
- C12M 45/02: {by mechanical forces; Stirring; Trituration; Comminuting (crushing, pulverizing, disintegrating in general B02C)}
- B01L 2200/04: Exchange or ejection of cartridges, containers or reservoirs
- B01L 2200/0668: Trapping microscopic beads
- B01L 2200/10: Integrating sample preparation and analysis in single entity, e.g. lab-on-a-chip concept
- B01L 2200/16: Reagents, handling or storing thereof
- B02C 19/0056: {specially adapted for specific materials not otherwise provided for}
- G01N 2001/2866: {Grinding or homogeneising}
- G01N 2001/2873: {Cutting or cleaving}
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- B01L: CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE
- B02C: CRUSHING, PULVERISING, OR DISINTEGRATING IN GENERAL; MILLING GRAIN ({household tools and machines for pulverising foodstuffs, e.g. coffee and spice mills A47J42/00; pharmaceutical mortars A61J3/02; mechanical processing of refuse and garbage B03B9/06; dressing mould materials by grinding B22C5/04}; obtaining metallic powder by crushing, grinding or milling B22F9/04; {recovery of plastics by disintegrating B29B17/00; crushing raw materials in starch making C08B30/02; beaters for papermaking D21D1/02; crushing devices specially for transport in mines E21F13/002; slag crushing devices F23J1/00; fuel milling devices in combustion apparatus F23K1/00; household devices for crushing coal F24B15/02; ice disintegrating devices F25C5/02})
- C12M: APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; {APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS}

## Abstract

A cartridge for dissociating tissue, comprising: a processing chamber comprising a stator, a side wall, a top orifice, and a first processing chamber port positioned in the side wall; and a grinder assembly comprising a plunger comprising a rotor, a grinder assembly slidably positioned in the processing chamber through the top orifice; wherein: the stator comprises a plurality of teeth arranged in a spaced-apart array of rings; and the rotor comprises one or more central teeth and a plurality of teeth arranged in a spaced-apart array of rings, wherein one ring of teeth is positioned at or substantially at a circumference of the rotor; wherein the rings in the stator and the rings in the rotor are positioned such that when the rotor contacts the stator, rings of teeth in the stator mesh with the one or more central teeth and rings of teeth in the rotor

## Claims

### Claim 1

A cartridge for dissociating tissue, comprising:
a processing chamber comprising a stator, a side wall, a top orifice, and a first processing chamber port positioned in the side wall; and
a grinder assembly comprising a plunger comprising a rotor, the grinder assembly slidably positioned in the processing chamber through the top orifice; wherein:
the stator comprises a plurality of teeth arranged in a spaced-apart array of rings; and
the rotor comprises one or more central teeth and a plurality of teeth arranged in a spaced-apart array of rings, wherein one ring of teeth is positioned at or substantially at a circumference of the rotor;
wherein the rings in the stator and the rings in the rotor are positioned such that when the rotor contacts the stator, rings of teeth in the stator mesh with the one or more central teeth and rings of teeth in the rotor.

### Claim 2 (depends on 1)

The cartridge of claim 1, further comprising a post-processing chamber comprising a port that fluidically communicates with the first processing chamber port, wherein the post-processing chamber comprises a single-cell suspension or single-nuclei suspension.

### Claim 3 (depends on 1)

The cartridge of claim 1, wherein a plurality of the teeth have a trapezoidal cross-section.

### Claim 4 (depends on 1)

The cartridge of claim 1, wherein the stator and the rotor each comprise three rings of teeth.

### Claim 5 (depends on 1)

The cartridge of claim 1, wherein the rotor comprises an inner ring comprising six teeth, a middle ring comprising six teeth and an outer ring comprising 11 teeth.

### Claim 6 (depends on 1)

The cartridge of claim 1, wherein the rotor comprises teeth at a density of about 1 tooth per 0.0025 mm2 to about 1 tooth per 0.10 mm2, e.g., about 1 tooth per 0.05 mm2.

### Claim 7 (depends on 1)

The cartridge of claim 1, wherein the stator comprises an inner ring comprising four teeth, a middle ring comprising six teeth and an outer ring comprising 10 teeth.

### Claim 8 (depends on 1)

The cartridge of claim 1, wherein the stator comprises teeth at a density of about 1 tooth per 0.002 mm2 to about 1 tooth per 0.08 mm2, e.g., about 1 tooth per 0.04 mm2.

### Claim 9 (depends on 1)

The cartridge of claim 1, wherein one or more teeth have a height of about 500 microns and a width of about 1 mm to 2 mm.

### Claim 10 (depends on 1)

The cartridge of claim 1, wherein the processing chamber has a volume between 5 mL and 100 mL, e.g., between 10 mL and 50 mL, e.g. between 10 mL and 20 mL.

### Claim 11 (depends on 1)

The cartridge of claim 1, wherein the processing chamber has a cross-sectional area of between about 78 mm2 (e.g., radius of about 5 mm) and about 1256 mm2 (e.g., radius of about 20 mm), e.g., about 452 mm2 (e.g., radius of about 12 mm).

### Claim 12 (depends on 1)

The cartridge of claim 1, comprising a tissue sample no greater than 20 mg, no greater than 10 mg, no greater than 5 mg, no greater than 2 mg, or no greater than 1 mg.

### Claim 13 (depends on 1)

The cartridge of claim 1, comprising a gap between the rotor and the sidewall of about 1 micron and 500 microns.

### Claim 14 (depends on 1)

The cartridge of claim 1, wherein the first processing chamber port is positioned above a top of the rotor when the rotor is fully depressed.

### Claim 15 (depends on 1)

The cartridge of claim 1, wherein the grinder assembly further comprises a cap attached to the plunger and configured to cover the orifice and position the grinder assembly in the processing chamber.

### Claim 16 (depends on 15)

The cartridge of claim 15, wherein the plunger is spring-biased toward the cap.

### Claim 17 (depends on 15)

The cartridge of claim 15, wherein the cap comprises a key slot to engage an actuator.

### Claim 18 (depends on 1)

The cartridge of claim 1, further comprising one or a plurality of:
a strain chamber comprising a strainer having pores no greater than about 40 microns (e.g., no greater than about 20 microns), and an optional second strainer having pores at least about 40 microns and no greater than about 200 microns; wherein the strain chamber communicates with the processing chamber through the second processing port;
a waste port that communicates with the third processing chamber port;
a post-processing chamber comprising: a first post-processing chamber port that communicates with the strain chamber; and a second post-processing chamber port; and a third post-processing chamber port; and
a vacuum trap comprising: a first vacuum trap port that communicates with the post-processing chamber through the second post-processing chamber port; and a second vacuum trap chamber port.

### Claim 19 (depends on 18)

The cartridge of claim 18, wherein the processing chamber and the post-processing chamber communicate through a fluidic channel.

### Claim 20 (depends on 18)

The cartridge of claim 18, wherein the third processing chamber port and the waste port communicate through a fluidic channel.

### Claim 21 (depends on 18)

The cartridge of claim 18, wherein the first strainer has pores no more than about 40 microns (e.g., no greater than about 20 microns) and the second strainer has pores between about 140 microns to about 200 microns.

### Claim 22 (depends on 18)

The cartridge of claim 18, wherein the first strainer has pores about 145 microns, the second strainer has pores about 40 microns and a third filter has pores of about 20 microns.

### Claim 23 (depends on 18)

The cartridge of claim 18, wherein the second processing port communicates with the post-processing chamber through a port in a cap of the post-processing chamber.

### Claim 24 (depends on 18)

The cartridge of claim 18, wherein the rotor of the plunger is biased toward the cap (e.g., spring biased).

### Claim 25 (depends on 18)

The cartridge of claim 18, wherein the rotor has sufficient clearance from the processing chamber walls to allow liquid, cells and nuclei to pass around the rotor during depression, and the first processing port is positioned above the rotor when fully depressed.

### Claim 26 (depends on 18)

The cartridge of claim 18, wherein the strain container is configured as an assembly comprising a basket and a lid, wherein the basket has an open top that is closed by the lid, the lid is attached to the plunger, wherein the assembly fits into the processing chamber, and wherein moving the plunger up and down along the Z axis moves the basket up and down through the solution.

### Claim 27 (depends on 18)

The cartridge of claim 18, wherein the second processing port is covered by a filter, e.g., a dual filter, having pores too small for cells and/or nuclei to pass.

### Claim 28 (depends on 18)

The cartridge of claim 18, wherein the second processing port communicates with the post-processing chamber through a port in a cap of the post-processing chamber.

### Claim 29 (depends on 18)

The cartridge of claim 18, wherein processing chamber, the post-processing chamber and the waste chamber communicate through fluidic channels that meet at a three-way junction and have one or more switchable valves.

### Claim 30 (depends on 18)

The cartridge of claim 18, comprising a valve between the processing chamber and the post-processing chamber and between the vacuum chamber and either or both of the processing chamber and the post-processing chamber.

### Claim 31 (depends on 18)

The cartridge of claim 18, further comprising a detection window.

### Claim 32 (depends on 18)

The cartridge of claim 18, further comprising a waste chamber comprising a first waste chamber port that communicates with the processing chamber.

### Claim 33

A cartridge comprising a rotor with an array of teeth including a center tooth, and complementary stator and outlet port connected to an instrument with a compartment containing a single-cell or single-nuclei suspension.

### Claim 34 (depends on 1, 18)

A system comprising:
(a) an instrument comprising:
(i) a cartridge interface configured to engage a cartridge;
(ii) a fluidic subsystem comprising:
(1) one or more fluid lines connecting the one or more containers with one or more fluid ports in the cartridge interface; and
(2) one or more pumps configured to apply positive or negative pressure to one or more fluid ports and to move liquids and/or gasses into and/or out of the one or more fluid ports
(3) an optional waste chamber communicating with a pump;
(iii) a physical dissociation subsystem comprising an actuator, a linear driver (e.g., a stepper motor or a pneumatic driver) that drives an actuator in an up-down (Z axis) direction, and a rotary motor that rotates the actuator around the Z axis; and
(iv) a control subsystem comprising a digital computer comprising a processor and memory, wherein the memory comprises code that, when executed by the processor, instructs the system to perform one or more operations;
(b) an enzymatic and chemical dissociation subsystem, which may be positioned inside or outside of the instrument, comprising:
(1) a reagent module comprising one or more containers containing one or more liquids and/or gasses and/or solids; and
(c) a cartridge of claim 1 or claim 18, releasably engaged with the cartridge interface, wherein:
(A) the first processing port is engaged with a first interface port in the cartridge interface that is connected with a pump that delivers reagents from the reagent module to the first cartridge port;
(B) the rotor assembly is engaged with the actuator;
(C) the waste port is engaged with a second interface port in the cartridge interface that is connected with a pump that positive or negative pressure to the waste port;
(D) the third post-processing chamber port is engaged with a third interface port in the cartridge interface that is connected with a pump that delivers reagents from the reagent module to the third post-processing port;
(E) the second vacuum trap port is engaged with a fourth interface port in the cartridge interface that is connected with a pump that positive or negative pressure to the waste port;
wherein the operations comprise introducing fluids from the reagent module into the processing chamber, introducing fluids from the reagent module into the post-processing chamber; stepping and/or rotating the rotor assembly, moving liquid from the processing chamber through the cartridge waste port; and moving a suspension from the processing chamber to the post-processing chamber.

### Claim 35 (depends on 34)

The system of claim 34, wherein the interface ports comprise fittings that engage the cartridge ports (e.g., nozzles, pogo pins, a flared connectors).

### Claim 36 (depends on 34)

The system of claim 34, wherein the control subsystem comprises a user interface configured to accept input from a user in the execution of the instructions.

### Claim 37 (depends on 34)

The system of claim 34, wherein the instrument further comprises one or more of:
(v) a magnetic post-processing module comprising a source of magnetic force, wherein the magnetic force is positioned to form a magnetic field in the post-processing chamber;
(vi) a measurement subsystem that performs optical imaging to measure titer, clumping, and/or viability of cells or nuclei or other characteristics of the sample in the cartridge; and
(vii) a temperature control subsystem comprising a heating and/or cooling element positioned to heat and/or cool the processing chamber and/or the post-processing chamber.

### Claim 38 (depends on 37)

The system of claim 37, wherein the measurement subsystem is configured to measure, at one or more time points, characteristics of a sample in the post-processing chamber.

### Claim 39 (depends on 38)

The system of claim 38, wherein the characteristic is selected from viability or degree of cell or nuclei dissociation or cell type or cell surface markers.

### Claim 40 (depends on 38)

The system of claim 38, wherein the characteristic is selected from degree of deparaffinization or rehydration.

### Claim 41 (depends on 37)

The system of claim 37, wherein the temperature control subsystem comprises a thermal transfer plate and a temperature controller, e.g., a Peltier, a strip resistive heater, one or more circulating fluids.

### Claim 42 (depends on 34)

The system of claim 34, wherein the containers contain one or more of: a deparaffinizing solution, a cross-link reversal solution, one or more rehydrating solutions, protease solutions, a buffer comprising a detergent, a lysis buffer, a resuspension buffer, dissociation solution, nuclei isolation solution, and nuclei storage solution.

### Claim 43 (depends on 42)

The system of claim 42, wherein the deparaffinizing solution comprises a compound that dissolves paraffin, e.g., xylene or a xylene substitute such as Citrisolv, Everclear™ Xylene substitute, Histoclear, etc.

### Claim 44 (depends on 42)

The system of claim 42, wherein the rehydrating solutions are selected from H2O and aqueous solutions of ethanol of different concentrations.

### Claim 45 (depends on 42)

The system of claim 42, wherein the protease solutions comprise one or more of proteinase K, a collagenase (e.g., collagenases type I, II, III, IV, and others), elastase, trypsin, papain, hyaluronidase, chymotrypsin, neutral protease, clostripain, caseinase, and neutral protease (Dispase®),

### Claim 46 (depends on 42)

The system of claim 42, wherein the lysis buffer comprises an aqueous buffer and a detergent.

### Claim 47 (depends on 42)

The system of claim 42, wherein the resuspension buffer comprises an aqueous buffer, and a compound for maintaining osmolarity compatible with cells and/or nuclei, e.g., bovine serum albumin.

### Claim 48 (depends on 42)

The system of claim 42, wherein the dissociation solution comprises one or more enzymes that cleave extracellular matrix.

### Claim 49 (depends on 42)

The system of claim 42, wherein the cross-link reversal solution comprises an enzyme or chemical that cleaves formalin cross-links, e.g., Proteinase K or IHC retrieval reagent.

### Claim 50 (depends on 42)

The system of claim 42, wherein the nuclei isolation solution comprises a buffer compatible with nuclei.

### Claim 51 (depends on 42)

The system of claim 42, wherein the nuclei storage solution comprises an aqueous buffer, a salt, and Ca++ and/or Mg++.

### Claim 52 (depends on 34)

The system of claim 34, wherein one of the pumps provides vacuum to a fluid port engaging the second vacuum trap port.

### Claim 53 (depends on 34)

The system of claim 34, wherein the actuator engages the rotor assembly through a drive fitting, e.g., slot, cross, phillips, polygon, or interlocking teeth.

### Claim 54 (depends on 34)

The system of claim 34, further comprising a barcode reader.

### Claim 55 (depends on 34)

The system of claim 34, further comprising:
(c) an analysis subsystem, wherein an input port of the analysis module communicates with the post-processing chamber.

### Claim 56 (depends on 55)

The system of claim 55, wherein the analysis system communicates with the post- processing chamber through a fluidic channel or fluid handling robot.

### Claim 57 (depends on 55)

The system of claim 55, wherein the analysis module performs an analysis selected from one or more of: DNA sequencing, next generation DNA sequencing, next generation DNA sequencing, proteomic analysis, genomic analysis, gene expression analysis, gene mapping, carbohydrate characterization and profiling, lipid characterization and profiling, flow cytometry, imaging, DNA or RNA microarray analysis, metabolic profiling, enzymatic assays, functional analysis, and mass spectrometry.

### Claim 58

A method comprising producing single cells or organelles from no more than 20 mg tissue with at least 70% of produced cells intact.

### Claim 59 (depends on 1, 58)

The method of claim 58, comprising:
providing no more than 20 micrograms of tissue in a processing chamber of the cartridge of claim 1;
grinding the tissue in the processing chamber with the teeth between the rotor and the stator to produce a suspension of single cells or organelles;
moving the suspension out of the processing chamber through the first processing chamber port.

### Claim 60 (depends on 59)

The method of claim 59, further comprising:
removing the suspension of biological material from the processing chamber.

### Claim 61 (depends on 59)

The method of claim 59, wherein the processing chamber further comprises one or more enzymes for digesting extracellular matrix.

### Claim 62 (depends on 59)

The method of claim 59, wherein the processing chamber further comprises one or more detergents for lysing cell membranes.

### Claim 63 (depends on 59)

The method of claim 59, wherein the processing chamber further comprises liquid having a viscosity that slows the rate of degradation of RNA or other biomolecules during or after tissue disruption.

### Claim 64 (depends on 59)

The method of claim 59, wherein disrupting comprises positioning a disruption surface of the head a defined distance from a bottom surface of the processing chamber and rotating the head to disrupt tissue in the processing chamber.

### Claim 65 (depends on 59)

The method of claim 59, wherein disrupting comprises positioning a disruption surface of the head with respect to a bottom surface of the processing chamber at a plurality of different gap distances and, at each gap distance, rotating the head.

### Claim 66 (depends on 65)

The method of claim 65, wherein at least one gap distance, at least some portion of the disruption head contacts some portion of the bottom surface.

### Claim 67 (depends on 65)

The method of claim 65, wherein the widest gap distance between a flat portion of the surface and flat portion of the bottom of the chamber is no more than any of 6 mm, 5 mm 4 mm, 3 mm, 2 mm, 1 mm, 500 um, 250 um, 100 um, 75 um, 50 um, 25 um, 20 um, 15 um, 10 um, 5 um, 4 um, 3 um, 2 um, or 1 um.

### Claim 68 (depends on 65)

The method of claim 65, wherein the plurality of gap distances between a flat portion of the grinding surface and flat portion of the bottom of the chamber is any of 2, 3, 4, 5, 6, 7, 8, 9 or 10 and the largest gap distance is no more than any of 6 mm, 5 mm 4 mm, 3 mm, 2 mm, 1 mm, 500 um, 250 um, 100 um, 75 um, 50 um, 25 um, 20 um, 15 um, 10 um, 5 um, 4 um, 3 um, 2 um, or 1 um.

### Claim 69 (depends on 65)

The method of claim 65, comprising:
disrupting tissue with the tissue disruptor;
incubating the disrupted tissue with at least one enzyme that digests extracellular matrix; and
disrupting the incubated tissue with the tissue disruptor.

### Claim 70 (depends on 59)

The method of claim 59, wherein the fluidic subsystem applies a vacuum to a cartridge port communicating with the processing chamber to move the suspension of biological material.

### Claim 71 (depends on 59)

The method of claim 59, wherein the cartridge further comprises a strainer and the suspension of biological material entering the processing chamber is strained to remove particulate matter.

### Claim 72 (depends on 59)

The method of claim 59, further comprising, after moving the suspension of biological material, using the fluidics subsystem to introduce a liquid into the processing chamber through a cartridge port and then using the fluidics subsystem to move the liquid into the processing chamber.

### Claim 73 (depends on 59)

The method of claim 59, further comprising, using the fluidics subsystem to introduce one or more liquids comprising one or more reagents through a cartridge port into the processing chamber.

### Claim 74 (depends on 73)

The method of claim 73, wherein the reagent comprises an enzyme or a particle comprising a binding agent (e.g., a binding agent directed against a target on a cell surface or a surface of a nucleus, virus or other biological target).

### Claim 75 (depends on 59)

The method of claim 59, wherein the tissue comprises a target cell and the method further comprises:
contacting the suspension of biological material in the processing chamber with solid particles comprising binding agents that bind to the target cells and sequester bound target cells within the suspension of biological material.

### Claim 76 (depends on 75)

The method of claim 75, further comprising separating the bound target cells from the suspension.

### Claim 77 (depends on 42)

The system of claim 42, wherein the single nuclei produced from FFPE are processed into a single nuclei library and sequenced.

### Claim 78 (depends on 34)

A method comprising:
deparaffinizing and rehydrating an FFPE tissue sample;
disrupting the deparaffinized and rehydrated FFPE tissue sample using a system and cartridge as described herein (e.g., a system of claim 34);
isolating cells and/or nuclei individually or in groups from the disrupted sample; and
generating an adapter-tagged nucleic acid library from nucleic acid from the isolated cells and/or nuclei.

### Claim 79

The method of embodiment 78, wherein generating the adapter-tagged library comprises hybridizing left hand side and right hand side nucleic acid probes to sequences in mRNA molecules in the isolated cells and/or nuclei, ligating the probes, and performing primer extension of the ligated probe with a primer comprising a recognition sequence and a barcode.

### Claim 80

The method of embodiment 78, wherein generating the adapter-tagged library comprises isolating nucleic acids from the isolated cells and/or nuclei, and attaching adapter molecules.

### Claim 81

The method of embodiment 78, wherein the tissue sample is deparaffinized and rehydrated in a system and cartridge as described herein.

### Claim 82

The method of embodiment 78, wherein the nucleic acid is DNA or RNA, e.g., mRNA.

### Claim 83

The method of embodiment 78, further comprising sequencing the nucleic acid library, e.g., by DNA cluster sequencing.

### Claim 84 (depends on 1)

A method comprising using a cartridge as disclosed herein (e.g., a cartridge of claim 1) to produce at least two million nuclei from an FFPE tissue sample.

### Claim 85 (depends on 84)

The method of claim 84, comprising producing at least 9 million nuclei or at least 12 million nuclei or from an FFPE tissue sample.

### Claim 86 (depends on 84)

The method of claim 84, comprising producing at least two million nuclei from a tissue sample of no more than 5 mm3.

### Claim 87 (depends on 84)

The method of claim 84, comprising producing at least two million nuclei from a tissue sample of no more than 10 mm3.

### Claim 88 (depends on 84)

The method of claim 84, comprising producing at least two million nuclei from a tissue sample of no more than 11.25 mm3.

### Claim 89 (depends on 84)

The method of claim 84, comprising producing at least two million nuclei from a tissue sample of no more than 15 mm3.

### Claim 90 (depends on 84)

The method of claim 84, comprising producing at least two million nuclei from a tissue sample of no more than 20 mm3.

### Claim 91 (depends on 34, 84)

The method of claim 84, comprising producing the nuclei using a system as disclosed herein, e.g., a system of claim 34.
